COMING SOON

Vyzulta (latanoprostene bunod ophthalmic solution)

injection
100 % legal and regulated
Secured logistics globally
24/7 track & trace delivery
Safe payment by bank transfer or credit card

We are registered as an independent intermediary for medicines with the Dutch Ministry of Health
COMING SOON

Vyzulta (latanoprostene bunod ophthalmic solution)

This product, although approved, is not yet available to purchase via TheSocialMedwork. However, if you are interested in staying informed please leave your email address, and we will update you as soon as we are able to source it and offer it for purchase.

Yes! I want to stay informed of developments with latanoprostene bunod ophthalmic solution.

Please leave your email address and we will inform you as soon as it's available to patients.

Send
Manufacturer Valeant Pharmaceuticals
Disease Glaucoma
Indication Open-angle glaucoma, Ocular hypertension
Mode of Action Prostaglandin analog
Approval Status FDA approved (USA)

Other medicines for glaucoma

If you are interested in other medicines for glaucoma, please visit our glaucoma page.

What is latanoprostene bunod ophthalmic solution?

Vyzulta (latanoprostene bunod ophthalmic solution) is a prostaglandin analog [1] approved by the FDA on November 2, 2017 [2], for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension [1]

Glaucoma is an eye disease characterized by the loss of vision or even blindness due to damage to the optic (eye) nerve; the damage is often associated with elevated pressure in the eye [3]. Glaucoma is the leading cause of irreversible blindness in the world [3].

Intraocular pressure is a major modifiable risk factor for glaucoma progression [1]. Vyzulta (latanoprostene bunod ophthalmic solution) is the first prostaglandin analog which can provide consistent and sustained lowering of intraocular pressure [2]. It is thought to lower intraocular pressure by increasing outflow of aqueous humor from the eye and in this way it reduces risk of glaucomatous visual field loss [1].

When will latanoprostene bunod ophthalmic solution be available?

Vyzulta (latanoprostene bunod ophthalmic solution) was approved by the FDA on November 2, 2017 [2]. We have already contacted our sourcing partners and we will offer this product on our website as soon as we are able to source it for our patients.


References
[1] Summary of Product Characteristics [FDA]: Vyzulta (latanoprostene bunod ophthalmic solution), Valeant Pharmaceuticals, Nov. 2017.
http://www.bausch.com/Portals/69/-/m/BL/United%20States/USFiles/Package%20Inserts/Pharma/vyzulta-prescribing-information.pdf
[2] Drugs.com. FDA Approves Vyzulta, 2/11/2017.
https://www.drugs.com/newdrugs/fda-approves-vyzulta-latanoprostene-bunod-ophthalmic-solution-open-angle-glaucoma-ocular-4626.html
[3] MedicineNet. Glaucoma. (last update: 20/10/2016), cited on 20/12/2017
https://www.medicinenet.com/glaucoma/article.htm

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.

How can we help?

β˜… β˜… β˜… β˜… β˜…
 
 

We've received requests for support from patients and doctors in over 120 countries, and delivered medicines to 6 continents. They've given us a 5 star rating for our service. Read what our friends from around the world are saying...

"My experience has been excellent. TheSocialMedwork were totally knowledgeable about the medicine I was looking for, and how to get it delivered to me quickly and easily. I UNCONDITIONALLY recommend TSM to anyone, it is truly a world-class organisation."

β€” Charles, USA

"During the transaction process I was very well informed by TheSocialMedwork team. They have put so much effort to ensure the best service was offered to me. Moreover the medicine I ordered was imported two weeks earlier. I highly recommend TheSocialMedwork."

β€” Tomasz, Poland

"I hope you know how needed you are and what it means to get a prompt, succinct and helpful reply. You are our hero. You have given us realistic hope in obtaining needed drugs in a timely way."

β€” Regina, US

"TheSocialMedwork were so helpful in getting the right medication to me, expediting its delivery, and keeping in touch. They simply can't do enough to help you. I would not hesitate to recommend TheSocialMedwork to anybody. Lovely people."

β€” Stephen, UK

"Totally awesome! Keep up the great work you're doing!"

β€” Dee, Australia

"When the doctor tells you that there are no treatments left to try, search further - there may be new treatments in other countries."

β€” Charlotte, The Netherlands

"TheSocialMedwork's professional capabilities, kindness and patience deserve our gratitude and respect."

β€” Haoyu, China

"My daughter died at the age of 21 because she couldn't get the treatment that might have saved her life. Now TheSocialMedwork might be able to help people like Abigail to get the best treatment."

β€” Frank, Virginia, USA

"The team is highly professional, friendly and will take care of everything. More options for doctor and patients. This service is transparent, unique and necessary. Keep it up!"

β€” Pa Tric, Germany

"Excellent communication and clarifications given every time when requested. They also provide fantastic support and updates from the start till the end of the process of the medicine provisioning."

β€” Milos, Serbia & Montenegro

Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.



Our service uses cookies.